Johnson & Johnson draws the ire of hospitals and the government over a planned change to how it will provide discounts for some of its 340B-eligible drugs. Pfizer becomes the second drug company to get into the direct-to-consumer market. Those stories and more coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.